Description	Product Code	Size
Pooled Human Serum	LQ-PHS-100	100 ml
	LQ-PHS-1000	1000 ml

POOLED HUMAN SERUM (PHS)

Pooled Human Serum (PHS) is collected from AB blood groups of non-transfused fasting male donors. The PHS contains no anti-coagulants and is heat-inactivated to remove complement activity.
(non-heat inactivated upon request) Bulk quantities available.

Pooled Human Serum sold by Labquip Ltd is collected at FDA-licensed commercial donor centers within the USA. Each unit is tested and found negative for: HBsAg, HCV, HIV-1, HIV-2, HIV-1Ag or HIV 1-NAT, ALT, and syphilis by FDA-Approved Methods.

Each lot of Pooled Human Serum (PHS) is aseptically pooled and sterile filtered.

RECOMMENDED USAGE:

In Cell Culture: as a protein supplement, the recommended concentration for support in cell culture for each lot of Pooled Human Serum ranges from 10-15%. This should be considered a guideline and we suggest each laboratory further evaluate the Pooled Human Serum to establish optimum concentration for their individual use in cellular assays.

Pooled Human Serum is also used as Negative control in Elisa and in serological HLA Typing. Pooled Human Serum can also be used as a diluents or negative control in microlymphocytotoxicity and flow cytometric assays. PHS supports Mixed Lymphocyte Culture (MLC) and Mitogen (PHA) Response.

Quality Assurance also includes testing for sterility, pH, osmolority, presence, or absence of Mycoplasma, endotoxin and presence of Human Leukocyte Antigen (HLA Ag) by Complement Dependent Cellular Cytotoxicity (CDCC) and flow cytometry.

All Pooled Human Serum (PHS) products are produced under cGMP standards and regulations.

CAUTION:

The Human Pooled Serum that you purchase from Labquip Ltd clearly labeled "For in Vitro Use Only". To comply with U.S. Food and Drug Administration (FDA) Regulations, these products are not for use in Therapeutic Procedures. It is not to be used in humans or animals. The user assumes all responsibility for its usage and disposal, in accordance with all regulations. No known test method can offer complete assurance that Hepatitis B virus, Hepatitis C virus, HIV-1, HIV-2, or other infectious agents are absent. All human blood based products should be handled in accordance with currently acceptable biosafety practices and guidelines for the prevention of blood-borne viral infections.